Nanostics Inc. (CNW Group/Nanostics)
EDMONTON, June 4, 2019 /PRNewswire/ – Nanostics Inc., a company developing a novel liquid biopsy platform for the early diagnosis of clinically significant prostate cancer, is…
In Canada, one in nine men will be diagnosed with prostate cancer in their lifetime. When detected early, prostate cancer is one of the most successfully treated types of cancer.
The staff and volunteers at Calgary’s Prostate Cancer Centre are dedicated to educating men about the importance of early detection.